Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19

Corona virus is quickly spreading around the world. The goal of viral management is to disrupt the virus’s life cycle, minimize lung damage, and alleviate severe symptoms. Numerous strategies have been used, including repurposing existing antivirals or drugs used in previous viral outbreaks. One suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Rajashri R., Shakya, Ashok K., Aladwan, Safwan M., El-Tanani, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014181/
https://www.ncbi.nlm.nih.gov/pubmed/35444538
http://dx.doi.org/10.3389/fphar.2022.806568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014181/
https://www.ncbi.nlm.nih.gov/pubmed/35444538
http://dx.doi.org/10.3389/fphar.2022.806568

Ejemplares similares